U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)
This funding opportunity supports collaborative research projects between U.S. and South African scientists focused on addressing critical issues related to HIV/AIDS, including its co-morbidities and implementation science.
The NIH’s U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (RFA-AI-24-023) seeks to fund research that addresses critical areas in HIV/AIDS, including co-morbidities, co-infections, implementation science, and data science related to HIV/AIDS. This program focuses on fostering international collaboration between South African and U.S. investigators to drive scientific advancements, share innovative technologies, and respond to public health priorities tied to the global HIV/AIDS crisis. The maximum award amount is set at $400,000, but the NIH has not specified a total funding allocation or the expected number of awards. Eligible applicants include both U.S. and non-U.S. organizations, with a specific focus on supporting collaborations with South African entities. However, non-U.S. components of U.S.-based organizations are not eligible to apply independently. Applications must be submitted by March 12, 2025, following the posting date of September 17, 2024. For comprehensive eligibility and submission guidelines, applicants are advised to review the full funding opportunity announcement or contact NIH Grants Information.
Award Range
Not specified - $400,000
Total Program Funding
$3,800,000
Number of Awards
10
Matching Requirement
No
Eligible Applicants
Additional Requirements
Eligible Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) Eligible Applicant Organizations must be from South Africa, as described below An eligible National Research Foundation (NRF) South African Institution is a recognized South African public higher education or research institution such as a university, university of technology, science council, museum or other research institution as declared by the Department of Science and Innovation. Historically disadvantaged institutions (HDIs) include: Mangosuthu University of Technology Sefako Makgatho Health Science University University of Fort Hare University of Limpopo University of the Western Cape University of Venda University of Zululand Walter Sisulu University South African Universities of Technology include: Cape Peninsula University of Technology Central University of Technology Durban University of Technology Sol Plaatje University Tshwane University of Technology University of Mpumalanga Vaal University of Technology
Geographic Eligibility
All
Application Opens
September 17, 2024
Application Closes
March 12, 2025
Subscribe to view contact details